Mar 10 2010

I have symptoms of H1N1 Swine Flu

Category: TamifluPrescription Search @ 9:20 am

How do I know if I have symptoms of Swine Flu? Are the swine flu symptoms of children the same as H1N1 symptoms adults? Let us know the answer to the question “Do I have symptoms of Swine Flu?”

Swine Flu is a number one health concern the world over. The HI1N1 flu or Swine Flu was first detected in US in April 2009. The worst affected areas initially were Canada and Mexico before swine flu cases began to emerge in other areas of the world. In a short span of four months, the disease has spread to almost all regions in the world. World Health Organization has called H1N1 as pandemic which means a big epidemic that involves the entire country or perhaps the world. Usually, the signs of a pandemic are when a virus without any immunity to stop it, spreads across various parts of the world.

Risk factors of Swine Flu

Swine Flu spreads from person to person in the same way as regular seasonal influenza viruses spread. People with high risk for seasonal flu are also at high risk for Swine Flu. For example, people above 65 years of age, pregnant women, children below 5 years of age and those with chronic medical conditions and lifestyle diseases like diabetes are at high risk of getting swine flu.

Symptoms of Swine Flu

In children, the symptoms of swine flu include:
1. Rapid Breathing or Difficulty in breathing.
2. Grayish or Bluish Skin Color
3. Dehydration

4. Persistent of severe vomiting
5. Not able to interact properly with people, become irritable
6. Flu like symptoms, bad cough and fever

In adults, the symptoms of swine flu include:
1. Shortness of breath or difficulty in breathing
2. Pain in chest or abdomen
3. Sudden dizziness or loss of energy
4. Severe or continuous vomiting
6. Flu like symptoms, bad cough and fever

The symptoms of H1N1 swine flu is similar to the ones that people get in regular, seasonal flu and so things like fever, sneezing, cough, body ache, head ache, shivering, sore throat and fatigue are common. Diarrhea and vomiting are also symptoms that have been associated with some cases of swine flu.

How do I catch swine flu?

H1N1 Swine Flu is transmitted the same way like seasonal flu. Flu viruses are spread usually from person to person through sneezing or coughing by people who have influenza. Some people may become infected with the deadly H1N1 by touching something that has virus on it and then bringing to their nose or mouth

How can someone with swine flu infect it to someone else?

Infected people can actually infect others from the first day itself, even before they themselves get any symptoms. This means there are also chances that one can pass on the symptoms of swine flu even before she or he knows that she or he is sick.

How do I protect myself from swine flu? How can I take precautions against swine flu?

There is no vaccine that can protect you or be prevention against H1N1 Swine Flu. You can only maintain hygiene and take care to prevent spread of germs that can lead to illnesses like influenza. Here are the ways in which you can prevent yourself against swine flu:

1. Cover your mouth and nose with a tissue when you sneeze or cough. Throw the tissue in the trash after you sneeze into it.

2. Wash your hands with a liquid handwash like Dettol or Lifebuoy, especially after you cough or sneeze.

3. Do not touch your mouth, eyes or nose. Germs can spread in this manner.

4. Avoid contact with people who are infected with swine flu. This is sad but then the disease is highly infective.

5. If you are sick with influenza, stay at home and do not go to school or work. Limit your contact with people so that they do not get infected.

6. Do not venture into crowded spaces.

7. Increase the airflow in your room by opening the windows for proper ventilation.

8. Sleep well, eat nutritious food and practise healthy habits so that you are physically active and immune to the flu

How long can the Swine Flu virus stay on things like doorknobs and furniture?

According to medical experts, the influenza virus can stay on environmental surfaces and infect people from 2 to 8 hours after being deposited on things like door knobs, books etc. Germs of swine flu can spread when a person touches infected areas or infected people and then touches their eyes, ears, nose or mouth. Cough droplets or sneeze from an infected person can travel through the area. When a person comes in contact with droplets of sneeze of another person or touches things like books or desk of that person that is contaminated with sneeze droplets, and touches his or her own eyes, mouth, nose etc; before washing hands, one can contract H1N1 virus.

What are the medicines and treatment options for H1N1 swine flu?

Taking oseltamivir(Tamiflu) or zanamivir(Relenza) can treat swine flu or H1N1 but they should be taken in the early stages of the disease. Antiviral drugs or prescription medicines can make your immune system strong and keep the flu viruses at bay and stop them from reproducing in your body. So, you should start taking antiviral drugs within two days of getting H1N1 or influenza symptoms.

How do I prevent getting H1N1 (Swine flu) in high risk areas?

If you live in places where people have been infected with H1N1 (Swine Flu) virus or have influenza like symptoms mentioned above, then you should stay home and avoid contact with these people. If you develop flu like symptoms, do not leave things to chance and take instant medical care. Your health care provider or doctor will be able to tell you whether H1N1 flu testing is required.

Does WHO recommend using a MASK?

If you are not sick or if you are not living in high risk areas, it is not required to wear a mask. If a near and dear one is sick with H1N1, you need to wear a mask since you will be in close contact with the ill person. Dispose the mask after contact and wash and clean your hands thoroughly. Using the mask correctly is important because using it incorrectly will spread infection.

How can I differentiate between H1N1 Swine Flu and seasonal flu?

You cannot tell the difference between HI1N1 Swine Flu and Seasonal Flu without a medical verdict on it. Since symptoms for both the diseases are same like cough, headache, sneezing, fever, runny nose etc, only your doctor will be able to say if you have H1N1 virus. In case, your doctor suspects symptoms, they will have your blood sample, nasopharyngeal (nose to mouth) and throat swab to laboratories.

Home remedies for swine flu:

There are no home remedies for swine flu, especially when you have to figure out if it is swine flu or season flu. Swine Flu requires anti-viral drugs because treating it is an emergency issue. However you can prevent the spread of swine flu and strengthen your immune system by doing the following:

Wash your hands properly before having a meal, not just with soap and water. Wear face mask before going outside. If someone is coughing or sneezing near you, cover your nose and mouth with palms or a hanky. Swine flu gets into the body through the mouth and nose. Drink lemon balm tea because it has anti-viral properties. Chew fresh garlic cloves because they have antiviral properties as well. Steam inhalation with chamomile or eucalyptus thrice a day can relieve lung congestion and prevent swine flu symptoms

Know more about Swine Flu treatment and also discuss Swine Flu Precautions

Tags: , ,


Mar 10 2010

Swine Flu H1N1 virus influenza 9.0

Category: TamifluPrescription Search @ 1:21 am

tamiflu

Image taken on 2009-10-02 20:57:42 by hitthatswitch.

Tags: , , ,


Mar 09 2010

what happens if tamiflu medicine is taken for normal influenza and later i am infected with H1N1?

Category: TamifluPrescription Search @ 11:11 pm

will it work properly with H1N1 virus

Tags: , , , , , , , ,


Mar 09 2010

H1N1 Virus Vaccination Scheduled For October

Category: TamifluPrescription Search @ 4:14 pm

The H1N1 virus, better known as the swine flu, is projected to be a major threat this winter. We hear about this virus in the news and are aware of its existence, but most of us are not aware of its history or the effectiveness of the vaccines that were created to treat this strain of influenza. I chose to research information about the H1N1 virus to make a more educated decision on whether or not I should have my daughter vaccinated.

The presence of this virus was brought to our attention in the spring of 2009 when the Mexican government began closing most of the public facilities in Mexico City due to an outbreak. Evidently, there was already a case of widespread swine flu there before it caught our attention. It spread to the United States as well as many other countries by June of 2009. The swine flu dates back to 1918 when it was commonly referred to as the Spanish Flu, though its origin was never detected. Five hundred million people were affected world-wide and 50 to 100 million people died as result. The virus attacked people with healthy immune systems and the popular idea that children and elderly people would be affected the most was not the case. A healthy immune system would over-do itself to try to beat the virus and in the meantime, it would overreact and actually have the reverse effect on the body.

A strain of H1N1 was responsible for a smaller outbreak in 1976 where a soldier at Fort Dix died right after complaining of not feeling well. This strain was controlled, but a new one was born right after which spread very quickly. A vaccination was created to prevent the re-occurrence of the epidemic that took so many lives in 1918. The vaccination helped with the spread of the virus, but it ended up taking more lives than the virus itself. Many died as the result of adverse reactions to the vaccine and 532 people were diagnosed with Guillian-Barré syndrome as a direct result from taking it. This is an autoimmune disorder that results in nerve damage among many other debilitating health problems. Many people who have Guillian-Barré syndrome need to undergo a form of dialysis where antibodies are removed from the blood and the blood is replenished back to the body. It is possible to survive this health condition but there is usually a long road to recovery which can take many years.

There was a limited case of swine flu labeled as Zoonosis which was detected in 1988 when a pregnant woman in Wisconsin died after being in contact with infected pigs at a fair. There were a few others who came in contact with her that were infected with a mild form of the virus. Many pigs were found to be infected across the entire U.S. in 1998 and it was deemed that the pigs had a typical flu that transformed into a new strain due to a combination of their own flu fused with those of humans and birds. Many pigs were infected in the Philippines in 2007 as well. The H1N1 virus is a combination of influenza spun from four different forms including 2 parts human flu, 1 part bird flu and 1 part pig flu.

The 2009 H1N1 virus exhibits symptoms that are similar to your everyday flu. These include a sudden fever and cough along with any of the other common flu symptoms like chills and body aches. Most people who catch the virus can treat it as they normally would with bed rest and fluids. People who have a weakened immune system can experience further complications like pneumonia or even respiratory failure. Those who are considered to be at a higher risk are people under 5 and over 65 years old. People who have recently undergone asthma treatments by taking prescription drugs are also at risk. H1N1 can have an incubation period of up to 7 days, though this has not been confirmed. It can be acquired the same way as the common flu through something as simple as a sneeze. One out of 1,000 people died of the swine flu which is comparable to the amount of people who have died from common flu. The best way to prevent from getting sick is by routine hand washing and covering your mouth and nose with a tissue when you sneeze or cough and quickly disposing it.

How do we know if we have a common flu or the swine flu? In most cases we don’t and physicians normally do not test patients to differentiate which virus they have. They will conduct a test if the symptoms are severe by administering a blood test or swabbing the back of the nose and throat. H1N1 is usually treated with Tamiflu or Relenza when it is diagnosed. These are antiviral medications that are used to treat the symptoms until the virus runs its course. The fact that most people are not tested for the H1N1 virus is concerning.

The numbers of people who actually carry this virus has to be unknown if everyone infected with flu symptoms has not been tested. Even though most people with this virus have a mild form of it, I would think that The World Health Organization and the Centers for Disease Control and Prevention would want to know how many cases are out there whether the infected people have severe symptoms or not. If this virus is more widespread than we think, perhaps it’s possible for an even larger strain to develop that we are not prepared for. I’m wondering why it is recommended to be vaccinated this year to prevent this illness if there is not enough concern for doctors to even test for it. The fatality rate is the same for the H1N1 virus as it is for the common flu and most of us have functioned just fine without a vaccination for that.

The H1N1 vaccination is not a cure for the virus as it is simply a preventative measure. Flu vaccines are on average 70-80% effective according to information provided by Fox News. Keep in mind that if you take this vaccine, you will be injected with a form of the virus that has been grown inside chicken eggs in a laboratory. Testing for the product’s safety just began earlier this month and it is already deemed to be safe. It is now being “tested” on pregnant women and children. Are these pregnant women and parents of these children who are being “tested” willing participants? It is possible for a person to develop immunity about 5 weeks after the vaccination process is complete, allowing you to fall victim to the virus in the meantime.

This is due to the fact that each person will need at least two rounds of the vaccine for it to be effective. It is said that there will only be a portion of the vaccines available in October, then more vaccinations will be released each month thereafter. Is this a way to test the vaccine that was just recently reconstructed from the same type of vaccine that was administered in 1976? This is not all that concerns me. They will also be throwing in additives that have never been tested to the second batch of vaccines. How long will they test that batch if it hasn’t even been created yet?

Do I want to vaccinate my daughter? I think not, and I hope it does not become mandatory. I have weighed the pros and cons of getting her vaccinated. Do I take extra precautions so my daughter does not get the virus that is practically identical to the common flu? Keeping her safe from the flu doesn’t seem as important as preventing the problems that can occur from taking the vaccine. The vaccine administered in 1976 and the cases of Guillain-Barré syndrome that resulted from it is concerning. I would rather my child have a mild form of the flu than to die from her immune system attacking her nervous system later in life. Neurologists have already been alerted to keep their eyes open for new cases of Guillain-Barré syndrome when the vaccination is released. It seems that the risks outweigh the benefits with this vaccine, but it’s not easy for drug companies to turn down an opportunity to make a killing in revenue.

Tags: , , , ,


Mar 09 2010

coffee break in H1N1 influenza times… ;-)

Category: TamifluPrescription Search @ 4:20 am

tamiflu

Image taken on 2008-01-13 17:17:30 by colodio.

Tags: , , , ,


Mar 09 2010

Nurses protest H1N1 safety as vaccines are delayed

Category: TamifluPrescription Search @ 3:11 am

wake of the H1N1 swine flu pandemic.

The nurses argue that hospitals have failed to provide enough protections against swine flu for its members, this is nothing new. Neither hospitals nor governments have paid enough attention to biological events. And the current flu pandemic has obviously failed to ignite significant protective measures if nurses are now moved to strike.

As expected, vaccine supplies will be even more scarce than government projections. This means 28 million to 30 million doses, at most, will be divided around the country by the end of the month, not the 40 million-plus that states had been expecting. So far, Nevada has only received 71,600 vaccine doses, enough to vaccinate less than three percent of the population. This has caused health districts to increase rationing.

Further, the governments failure to accelerate the use of experimental drugs, like Peramivir, to rescue patients on the brink of death, has frustrated both doctors and nurses. Peramivir is an antiviral drug like Tamiflu and Relenza. But unlike those drugs, it’s being studied as an intravenous treatment for critically ill patients. Human clinical trials in the U.S. and Japan have called Peramivir safe and effective. But the FDA has not approved it.

However, the FDA has made at least 20 Peramivir exceptions, for compassionate use upon request. In addition, the FDA is considering an Emergency Use Authorization, for the drug. This would allow the government to stockpile the drug and reduce most paperwork. The FDA says the changes are coming “fairly soon” – but doctors say they’re needed now.

There is no excuse for either the vaccination or emergency use delays. Flu is not a new event, and the medical community has been aware of H1N1 since April. Further, while American medical care may be the most expensive in the world, its quality is among the lowest. Research suggests that the United States spends more than twice as much on each person for health care as most other industrialized countries. But it has fallen to last place among those countries in preventing deaths through use of timely and effective medical care.

In addition, access to care in the United States has worsened with reports suggesting that between 40 and 75 million people lack adequate health insurance or are uninsured altogether. And within the nation, the cost and quality of care vary drastically.

In some cases, the nation’s progress has been overshadowed by improvements in other industrialized countries, which typically have more centralized health systems, which makes it easier to put changes in place.

The United States, for example, has reduced the number of preventable deaths for people under the age of 75 to 110 deaths for every 100,000 people, compared with 115 deaths five years earlier, but other countries have made greater strides. As a result, the United States now ranks last in preventable mortality, just below Ireland and Portugal, according to the Commonwealth Fund’s analysis of World Health Organization data. The leader by that measure is France, followed by Japan and Australia.

The swine flu pandemic is another lesson in the pathology of governance. And unless this pathology is immediately corrected the nation can expect an ever increasing death count. And should the nation experience a bio-terrorist attack by 2013, as projected by the Commission on the Prevention of Weapons of Mass Destruction the death count will be measured in millions.

Quoting & Saving just got easier…EasyToInsureME Health Insurance

California Health Insurance
Nevada Health Insurance

Tags: , , , , ,


Mar 09 2010

Rest Of World H1N1 (swine flu) Vaccination Market

Category: TamifluPrescription Search @ 2:11 am

Opportunity Analysis of H1N1 (swine flu) Vaccination Market

H1N1 Influenza A (2009) is the first pandemic influenza of 21st century affecting more than four lac people in more than 180 countries across the globe in 2009. The flu broke in Mexico in the month of March and then affected U.S. and after that it spread across the globe. H1N1 (2009) influenza have a mutation of pig, bird and humans which has made it more dangerous and fatal compared to previous occurrence of H1N1 (1918). ( http://www.bharatbook.com/Market-Research-Reports/Opportunity-Analysis-of-H1N1-swine-fluVaccination-Market.html )

The pandemic outbreak of the influenza opened the gates for the drugs such as Tamiflu in the initial phase for the curing of the disease but the following phase will see a shift from curing to prevention. Thus, arise the requirement for the vaccine for the treatment of H1N1. H1N1 vaccine market is the forecast for the upcoming vaccines for the prevention of the disease among the unaffected population. The vaccines market is classified for the intramuscular vaccines and intranasal vaccines. Intramuscular will cater 80-85% of market revenues and the remaining will be tapped by the intranasal vaccines. The initial lot of vaccines will be of egg based and cell based manufacturing. The market forecast is from late 2009 as the first lot of doses are expected to be rolled out in the first week of October 2009.

The first movers of the in the vaccines market are Glaxo Smith Kline (GSK), Novartis, CSL, Medimmune, Baxter, Sinovec and Sanofi Pastuer. Medimmune is the only producer of the intranasal vaccine whereas other companies are expected to come out with intramuscular vaccines. The companies have got approvals for their first lots from the governments of the various countries such as U.S., U.K., France, China, Denmark and Australia. The involvement of government bodies, increased awareness about prevention and pandemic situation of the influenza is driving the market for the vaccines. Due to intensive ongoing research and technology introduction, the market players are compelled to understand the market dynamics, innovations, pricing, products, marketing and regulatory framework of the market.

The global H1N1 Influenza vaccine market is estimated to be of 676 million in 2009 with first lot of doses being commercialized on 30th September’ 2009. The market will see a high CAGR for the next two years i.e. the market is expected to be at $7.03 billion in 2011 with a CAGR of 222.4% from 2009 to 2011. However, the very high CAGR will settle down by 2012 to 30% for the period of 2009 to 2012. The reason for the sudden settle down of the growth is that it is expected that most of the world population will be immunized by the end of 2011.

Market estimates and forecast

* This report will enable strategic understanding and opportunities in the H1N1 2009 influenza vaccines market. The report covers the following market segments.
* Vaccines Markets: Intramuscular Vaccines and Intranasal vaccines.
* Geography Markets: North America, Europe, Asia-Pacific and ROW

Each section of the report offers market data with respect to segments and geography. It also provides market trends with respect to drivers, restraints and opportunities. The report contains strategic section with respect to competitive landscape and market overview. The report will encompass around 15 company profiles.

To know more and to buy a copy of your report feel free to visit : http://www.bharatbook.com/Market-Research-Reports/Opportunity-Analysis-of-H1N1-swine-fluVaccination-Market.html

Or

Contact us at :

Bharat Book Bureau
Tel: +91 22 27578668
Fax: +91 22 27579131
Email: info@bharatbook.com
Website: www.bharatbook.com
Blog: http://bharatbookresearch.blogspot.com
Follow us on twitter: http://twitter.com/3bbharatbook

We are the leading information aggregator, facilitates and supports the business information needs. With over 115,000 reports, you can get instant access and insights on the studies in yo for market research , corporate / strategic planning by providing the latest information in the form of reports, journals, magazines and databases on varied industries like automotive, oil and gas, shipping, textiles, pharmaceuticals, energy, banking, finance, insurance, risk management, country intelligence, consumer & durable goods, chemical and more ur areas of interest. Contact us at +91 22 27578668 / 27579438 or email info@bharatbook.com or our website www.bharatbook.com

Tags: , , , , ,


Mar 08 2010

Opportunity Analysis of H1N1 (swine flu) Vaccination Market

Category: TamifluPrescription Search @ 7:13 pm

REPORT DESCRIPTION

H1N1 Influenza A (2009) is the first pandemic influenza of 21st century affecting more than more than four lac people in more than 180 countries across the globe in 2009. The flu broke in Mexico in the month of March and then affected U.S. and after that it spread across the globe. H1N1 (2009) influenza have a mutation of pig, bird and humans which has made it more dangerous and fatal compared to previous occurrence of H1N1 (1918).

The pandemic outbreak of the influenza opened the gates for the drugs such as Tamiflu in the initial phase for the curing of the disease but the following phase will see a shift from curing to prevention. Thus, arise the requirement for the vaccine for the treatment of H1N1. H1N1 vaccine market is the forecast for the upcoming vaccines for the prevention of the disease among the unaffected population. The vaccines market is classified for the intramuscular vaccines and intranasal vaccines. Intramuscular will cater 80-85% of market revenues and the remaining will be tapped by the intranasal vaccines. The initial lot of vaccines will be of egg based and cell based manufacturing. The market forecast is from late 2009 as the first lot of doses are expected to be rolled out in the first week of October 2009.

The first movers of the in the vaccines market are Glaxo Smith Kline (GSK), Novartis, CSL, Medimmune, Baxter, Sinovec and Sanofi Pastuer. Medimmune is the only producer of the intranasal vaccine whereas other companies are expected to come out with intramuscular vaccines. The companies have got approvals for their first lots from the governments of the various countries such as U.S., U.K., France, China, Denmark and Australia. The involvement of government bodies, increased awareness about prevention and pandemic situation of the influenza is driving the market for the vaccines.

Due to intensive ongoing research and technology introduction, the market players are compelled to understand the market dynamics, innovations, pricing, products, marketing and regulatory framework of the market.

The global H1N1 Influenza vaccine market is estimated to be of 676 million in 2009 with first lot of doses being commercialized on 30th September’ 2009. The market will see a high CAGR for the next two years i.e. the market is expected to be at $7.03 billion in 2011 with a CAGR of 222.4% from 2009 to 2011. However, the very high CAGR will settle down by 2012 to 30% for the period of 2009 to 2012. The reason for the sudden settle down of the growth is that it is expected that most of the world population will be immunized by the end of 2011.

Market estimates and forecast

This report will enable strategic understanding and opportunities in the H1N1 2009 influenza vaccines market. The report covers the following market segments.

Vaccines Markets: Intramuscular Vaccines and Intranasal vaccines.

Geography Markets: North America, Europe, Asia-Pacific and ROW

Each section of the report offers market data with respect to segments and geography. It also provides market trends with respect to drivers, restraints and opportunities. The report contains strategic section with respect to competitive landscape and market overview. The report will encompass around 15 company profiles

What makes our reports unique?

- We provide the longest market segmentation chain in this industry- not many reports provide market breakdown upto level 5.
- We provide 10% customization. Normally it is seen that clients do not find specific market intelligence that they are looking for. Our customization will ensure that you necessarily get the market intelligence you are looking for and we get a loyal customer.
- We conduct detailed market positioning, product positioning and competitive positioning. Entry strategies, gaps and opportunities are identified for all the stakeholders.
- Comprehensive market analysis for the following sectors:
Pharmaceuticals, Medical Devices, Biotechnology, Semiconductor and Electronics, Energy and Power Supplies, Food and Beverages, Chemicals, Advanced Materials, Industrial Automation, and Telecom and IT. We also analyze retailers and super-retailers, technology providers, and research and development (R&D) companies.

Key questions answered

- Which are the high-growth segments/cash cows and how is the market segmented in terms of applications, products, services, ingredients, technologies, and stakeholders?
- What are market estimates and forecasts; which markets are doing well and which are not?
- Where are the gaps and opportunities; what is driving the market?
- Which are the key playing fields? Which are the winning edge imperatives?
- How is the competitive outlook; who are the main players in each of the segments; what are the key selling products; what are their strategic directives, operational strengths and product pipelines? Who is doing what?

Powerful Research and analysis

The analysts working come from renowned publishers and market research firms, globally, adding their expertise and domain understanding. We get the facts from over 22,000 news and information sources, a huge database of key industry participants and draw on our relationships with more than 900 market research companies across the world. We are inspired to help our clients grow by providing qualitative business insights with our huge market intelligence repository.

For more information, please visit :

http://www.aarkstore.com/reports/Opportunity-Analysis-of-H1N1-swine-flu-Vaccination-Market-32318.html

Or email us at press@aarkstore.com or call +919272852585

Aarkstore Enterprise is a leading provider of business and financial information and solutions worldwide. We specialize in providing online market business information on market research reports, books, magazines, conference at competitive prices, and strive to provide excellent and innovative service to our customers. Our customers include more than 700 leading financial institutions, professional service firms, consulting, law and accounting firms and other corporations throughout the world.

Tags: , , , , ,


Mar 08 2010

Will Swine Flu (H1N1) become an Epidemic or Pandemic in 2010?

Category: TamifluPrescription Search @ 2:12 am

H1N1 influenza A is also commonly known as the swine flu. The swine flu is believed to have originated in Mexico and then quickly started spreading. The swine flu is a dangerous type of flu because it is a new strain. The swine flu is thought to be a combination of bird flu, swine flu and human flu. This particular strain of flu has the potential be become an epidemic in 2009 because people have never before been exposed to it and therefore don’t have any immunity built up against it.

This lack of immunity within the population is what has the makings of a possible epidemic or pandemic in 2009. An epidemic is when a higher than expected number of people contract seasonal flu in a specific area or part of the country. A pandemic is a global outbreak that is most often the result of a new strain of influenza. There have been many pandemics throughout history. The Spanish Flu outbreak of 1918 killed somewhere between 20 and 40 million people worldwide and is the most deadly pandemic in recent history.

Swine flu has already become global making a pandemic a real possibility. The World Health Organization (W.H.O.) provides global health leadership over the U.N. The WHO has a system in place for assessing the level of an influenza outbreak. This system has 6 phases of preparedness that rate the current level of influenza outbreak globally. The final level, phase 6, is the highest level of preparedness meaning the influenza has become a pandemic.

The CDC and WHO have been preparing for epidemics and pandemics for decades. Preparing for influenza outbreaks includes putting procedures in place that are used to get ready in case a flu outbreak occurs. The United States is extremely well prepared and ready to handle a flu outbreak. Preparations include educating local, regional and state resources in how to handle a flu epidemic or pandemic.

It is important that the public be aware of the ways that they can avoid getting and spreading the swine flu. Public awareness and participation will help to keep the disease under control. With today’s Internet, television and radio broadcasts the information about swine flu (H1N1) can be widely distributed to a major portion of the population. This helps to keep everyone aware of what they can do to help protect themselves and their families from getting the swine flu.

There is currently no preventative inoculation for this new strain of H1N1 influenza A; however, work is being done right now to come up with one. The current method of treatment for swine flu is to take Tamiflu, a prescription medication that is designed to help reduce the severity of the symptoms. Swine flu is not dangerous for most people who get it. The swine flu can lead to severe complications in those with lowered immune systems. Most often, however, swine flu does not require hospitalization and the patient can recover at home in a few days to a week.

Ricky Ahuja
www.informationonh1n1.com

Tags: , , , , ,


Mar 08 2010

H1N1 Virus Vaccination Scheduled For December Release

Category: TamifluPrescription Search @ 1:13 am

I chose to research information about the H1N1 virus to make a more educated decision on whether or not I should have my daughter vaccinated.
The presence of this virus was brought to our attention in the spring of 2009 when the Mexican government began closing most of the public facilities in Mexico City due to an outbreak. Evidently, there was already a case of widespread swine flu there before it caught our attention. It spread to the United States as well as many other countries by June of 2009. The swine flu dates back to 1918 when it was commonly referred to as the Spanish Flu, though its origin was never detected. Five hundred million people were affected world-wide and 50 to 100 million people died as result. The virus attacked people with healthy immune systems and the popular idea that children and elderly people would be affected the most was not the case. A healthy immune system would over-do itself to try to beat the virus and in the meantime, it would overreact and actually have the reverse effect on the body.
A strain of H1N1 was responsible for a smaller outbreak in 1976 where a soldier at Fort Dix died right after complaining of not feeling well. This strain was controlled, but a new one was born right after which spread very quickly. A vaccination was created to prevent the re-occurrence of the epidemic that took so many lives in 1918. The vaccination helped with the spread of the virus, but it ended up taking more lives than the virus itself. Many died as the result of adverse reactions to the vaccine and 532 people were diagnosed with Guillian-Barré syndrome as a direct result from taking it. This is an autoimmune disorder that results in nerve damage among many other debilitating health problems. Many people who have Guillian-Barré syndrome need to undergo a form of dialysis where antibodies are removed from the blood and the blood is replenished back to the body. It is possible to survive this health condition but there is usually a long road to recovery which can take many years.
There was a limited case of swine flu labeled as Zoonosis which was detected in 1988 when a pregnant woman in Wisconsin died after being in contact with infected pigs at a fair. There were a few others who came in contact with her that were infected with a mild form of the virus. Many pigs were found to be infected across the entire U.S. in 1998 and it was deemed that the pigs had a typical flu that transformed into a new strain due to a combination of their own flu fused with those of humans and birds. Many pigs were infected in the Philippines in 2007 as well. The H1N1 virus is a combination of influenza spun from four different forms including 2 parts human flu, 1 part bird flu and 1 part pig flu.
The 2009 H1N1 virus exhibits symptoms that are similar to your everyday flu. These include a sudden fever and cough along with any of the other common flu symptoms like chills and body aches. Most people who catch the virus can treat it as they normally would with bed rest and fluids. People who have a weakened immune system can experience further complications like pneumonia or even respiratory failure. Those who are considered to be at a higher risk are people under 5 and over 65 years old. People who have recently undergone asthma treatments by taking prescription drugs are also at risk. H1N1 can have an incubation period of up to 7 days, though this has not been confirmed. It can be acquired the same way as the common flu through something as simple as a sneeze. One out of 1,000 people died of the swine flu which is comparable to the amount of people who have died from common flu. The best way to prevent from getting sick is by routine hand washing and covering your mouth and nose with a tissue when you sneeze or cough and quickly disposing it.
How do we know if we have a common flu or the swine flu? In most cases we don’t and physicians normally do not test patients to differentiate which virus they have. They will conduct a test if the symptoms are severe by administering a blood test or swabbing the back of the nose and throat. H1N1 is usually treated with Tamiflu or Relenza when it is diagnosed. These are antiviral medications that are used to treat the symptoms until the virus runs its course. The fact that most people are not tested for the H1N1 virus is concerning.
The numbers of people who actually carry this virus has to be unknown if everyone infected with flu symptoms has not been tested. Even though most people with this virus have a mild form of it, I would think that The World Health Organization and the Centers for Disease Control and Prevention would want to know how many cases are out there whether the infected people have severe symptoms or not. If this virus is more widespread than we think, perhaps it’s possible for an even larger strain to develop that we are not prepared for. I’m wondering why it is recommended to be vaccinated this year to prevent this illness if there is not enough concern for doctors to even test for it. The fatality rate is the same for the H1N1 virus as it is for the common flu and most of us have functioned just fine without a vaccination for that.
The H1N1 vaccination is not a cure for the virus as it is simply a preventative measure. Flu vaccines are on average 70-80% effective according to information provided by Fox News. Keep in mind that if you take this vaccine, you will be injected with a form of the virus that has been grown inside chicken eggs in a laboratory. Testing for the product’s safety just began earlier this month and it is already deemed to be safe. It is now being “tested” on pregnant women and children. Are these pregnant women and parents of these children who are being “tested” willing participants? It is possible for a person to develop immunity about 5 weeks after the vaccination process is complete, allowing you to fall victim to the virus in the meantime.
This is due to the fact that each person will need at least two rounds of the vaccine for it to be effective. It is said that there will only be a portion of the vaccines available in October, then more vaccinations will be released each month thereafter. Is this a way to test the vaccine that was just recently reconstructed from the same type of vaccine that was administered in 1976? This is not all that concerns me. They will also be throwing in additives that have never been tested to the second batch of vaccines. How long will they test that batch if it hasn’t even been created yet?
Do I want to vaccinate my daughter? I think not, and I hope it does not become mandatory. I have weighed the pros and cons of getting her vaccinated. Do I take extra precautions so my daughter does not get the virus that is practically identical to the common flu? Keeping her safe from the flu doesn’t seem as important as preventing the problems that can occur from taking the vaccine. The vaccine administered in 1976 and the cases of Guillain-Barré syndrome that resulted from it is concerning. I would rather my child have a mild form of the flu than to die from her immune system attacking her nervous system later in life. Neurologists have already been alerted to keep their eyes open for new cases of Guillain-Barré syndrome when the vaccination is released. It seems that the risks outweigh the benefits with this vaccine, but it’s not easy for drug companies to turn down an opportunity to make a killing in revenue.

Stay updated on current news pertaining to the H1N1 virus on Fox News with DISH Network.

Tags: , , , , ,


« Previous PageNext Page »